Wearable Cardiac Devices Market Size, Share, and Trends 2024 to 2033

Wearable Cardiac Devices Market (By Product: Defibrillator, Holter monitors, Patch, Others; By Application: Home Healthcare, Remote Patient Monitoring, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : May 2024
  • Report Code : 4374
  • Category : Healthcare

Wearable Cardiac Devices Market Size and Growth 2024 to 2033

The global wearable cardiac devices market size was valued at USD 3.01 billion in 2023 and is anticipated to reach around USD 27.44 billion by 2033, growing at a CAGR of 24.73% from 2024 to 2033. The rising awareness and surging expenditure on health by the population is boosting the growth of the market.

Wearable Cardiac Devices Market Size 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Wearable Cardiac Devices Market Key Takeaways

  • The North America wearable cardiac devices market size accounted for USD 1.84 billion in 2023 and is expected to attain around USD 16.88 billion by 2033, poised to grow at a CAGR of 24.81% between 2024 and 2033.
  • North America led the wearable cardiac devices market with the largest market share in 2023.
  • Asia Pacific is expected to witness the fastest growth in the market during the forecast period.
  • By product, the defibrillators segment dominated the market in 2023.
  • By application, the home healthcare segment dominates the market and is expected to grow at the fastest rate during the forecast period.

U.S. Wearable Cardiac Devices Market Size and Growth 2024 to 2033

The U.S. wearable cardiac devices market size was estimated at USD 1.38 billion in 2023 and is predicted to be worth around USD 12.74 billion by 2033 with a CAGR of 24.89% from 2024 to 2033.

U.S. Wearable Cardiac Devices Market Size 2024 to 2033

North America led the wearable cardiac devices market with the largest market share in 2023. The market growth in the region is attributed to the rising cases of cardiac-related diseases in the population due to lifestyle habits and aging factors. The rising geriatric population is one of the major reasons for the higher number of chronic cardiovascular diseases in the region. The population's early adoption of technology in healthcare and the well-developed healthcare infrastructure are driving the expansion of the cardiovascular treatment ratio. The higher availability of the leading technology companies participating in the development of wearable healthcare devices contributes to the growth of the wearable cardiac devices market in the region.

  • For instance, 40% of adults in the U.S. are using any type of health application, and 35% are using wearable healthcare devices in 2023. According to the survey, the use of wearable healthcare devices increased by 8% from 2018, and healthcare application usage increased by 6% from 2018 to 2023. 47% and 40% of adults aged 18 to 34 use wearable and healthcare apps, respectively.
  • For instance, 38% of adults with cardiovascular diseases regularly use wearable devices. Almost or more than 80% of wearable device users share their regular health information with their physicians to support health monitoring.

Wearable Cardiac Devices Market Share, By Region, 2023 (%)

Asia Pacific is expected to witness the fastest growth in the market during the forecast period. The growth is owing to the expansion in population in the region's countries like India and China. The increasing prevalence of cardiac diseases in the population is driving the demand for regular health monitoring devices.

Additionally, the rising technological trend in healthcare wearable devices is driving the growth of the wearable cardiac devices market across the region. About 5–6 lakh Indians are thought to pass away from sudden cardiac death (SCD) each year, with a significant percentage of those deaths occurring in those under 50. In India, stroke ranks as the second most prevalent cause of death. In India, there are over 1,85,000 recorded stroke cases annually, with one stroke fatality occurring every four minutes and a stroke occurring every forty seconds.

The critical emphasis now turns to improving cardiac-related illness monitoring, early identification, and prevention tactics in light of these concerning developments. Indian cardiac care is undergoing a fundamental transformation thanks to recent technological developments. The emergence of smart gadgets has brought about a transformation in the field of cardiac care by providing more options for managing daily health. These developments provide people the ability to actively engage in their healthcare process and give medical professionals vital resources for better monitoring and treating heart issues.

Asia Pacific Wearable Cardiac Devices Market Size and Growth 2024 to 2033

The Asia Pacific wearable cardiac devices market size was calculated at USD 570 million in 2023 and is projected to expand around USD 5,350 million by 2033, poised to grow at a CAGR of 25.09% from 2024 to 2033.

Forecast Year Market Size in USD
2023 $570 Million
2024 $710 Million
2025 $710 Million
2026 $1,110 Million
2027 $1,380 Million
2028 $1,730 Million
2029 $2,150 Million
2030 $2,690 Million
2031 $3,350 Million
2032 $4,180 Million
2033 $5,350 Million

 

Wearable Cardiac Devices Market Overview

Wearable cardiac devices are one of the segments of wearable healthcare devices that are used to monitor and track the physical activity of patients suffering from any type of cardiac issues. Wearable devices are used to capture data by mobile sensors and generate behavioral and physiological insights like heart rate, physical activity, sleep, and heart rhythm. Wearable devices are minimally invasive and used for the diagnostics process.

The rising popularity of wearable healthcare devices is driving the demand for the wearable cardiac devices market. It helps in positively influencing lifestyle changes such as prevention measures, remote monitoring of patients, and arrhythmia screening of at-risk individuals with peripheral artery diseases and other chronic cardiovascular disorders. The rising geriatric population and the accepting sedentary lifestyle are causing an increased number of cardiac issues in people, driving the demand for the wearable cardiac devices market.

Wearable Cardiac Devices Market Growth Factors

  • The increasing prevalence of cardiovascular diseases among the population due to changing lifestyle habits, environment, and aging factors drives the demand for the wearable cardiac devices market.
  • The increase in the geriatric population, which is more likely to be affected by chronic diseases like cardiovascular diseases and diabetes, drives the demand for early treatment, which boosts the demand for the market.
  • Wearable cardiac devices are daily health activity trackers used by cardiac patients to manage their well-being. The devices give physicians accurate insights into the patient’s health so that they can make proper decisions regarding their health.
  • The rising preference for home healthcare and the increasing adoption of wearable healthcare devices like smartwatches, smart rings, and others are further contributing to the market's growth.
  • The technological evolution in healthcare and investments in research and development activities for the new launch of technologically advanced healthcare devices is accelerating the expansion of the wearable cardiac devices market.

Wearable Cardiac Devices Market Scope

Report Coverage Details
Wearable Cardiac Devices Market Size in 2023 USD 3.01 Billion
Wearable Cardiac Devices Market Size in 2024 USD 3.75 Billion
Wearable Cardiac Devices Market Size by 2033 USD 27.44 Billion
Wearable Cardiac Devices Market Growth Rate CAGR of 24.73% from 2024 to 2033
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Product, Application, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

 

Wearable Cardiac Devices Market Dynamics

Driver: Rising cases of cardiovascular diseases (CVD)

The rising chronic diseases like cardiovascular diseases, diabetes, and respiratory illness in the population due to the changing life standards, eating and sleeping habits, rising consumption of alcohol, and smoking increase the risk of chronic illness in the population. The increase in the geriatric population globally is one of the major factors that drive cardiovascular disease cases.

The increasing popularity of wearable devices in the healthcare industry is due to their beneficial properties, like healthcare monitoring and real-time insights into patient health. Wearable technology allows us to tackle cardiovascular diseases by personalizing atrial fibrillation management, refining stroke prevention strategies, and maintaining the physician-patient relationship. Thus, the rising awareness about wearable healthcare technologies is driving the growth of the wearable cardiac devices market.

For instance, cardiovascular diseases are the leading cause of death in the world. Among the total population, 620 million people live with circulatory and heart diseases worldwide. Every year, approximately 60 million people develop a circulatory or heart disease, which leads to 1 in 3 deaths globally.

Restraint: Regularities issues

The wearable cardiac devices market faces challenges in various regional markets due to strict regulations and lower awareness about these devices. Many countries have stringent regulations regarding adopting wearable healthcare devices, citing concerns about their accuracy. Additionally, limited awareness among the population about the benefits and capabilities of wearable cardiac devices hinders their widespread adoption.

This lack of understanding and acceptance contributes to the slower market growth in these regions. Overcoming these challenges will require efforts to educate healthcare professionals and the general public about the potential advantages of wearable cardiac devices and work towards meeting regulatory standards. By addressing these issues, the market for wearable cardiac devices may see increased acceptance and growth in regions where such challenges currently exist.

Opportunity: Advancements in wearable cardiac devices

Technological advancements in wearable cardiac devices help enhance the efficiency and accuracy of health monitoring systems. It improves the patient and physician experience by collecting data and monitoring ECG-based cardiac activities. The latest wearable cardiac devices can be worn all seven days, anywhere, due to their compact size, water resistance, lightweight, and disposable properties.

The advancements in wearable devices offer great efficiency and save time for both patients and physicians. It has the ability to track any symptoms without any issues. The rising geriatric population and the pandemic drive the sustainable growth of wearable cardiac devices in the global market due to the rising demand for home healthcare. Additionally, the increasing participation of major technology leading companies in wearable healthcare devices is further driving the opportunity for the wearable cardiac devices market. 

Product Insights

The defibrillators segment dominated the wearable cardiac devices market during the forecast period.  The increasing acceptance of cardioverter-defibrillators is enhancing the efficiency of monitoring and increases the survival rate at high risk of sudden cardiac death from ventricular tachyarrhythmia. The devices are responsible for continuous recording and transmission via modem in both bradyarrhythmias and tachyarrhythmia. Clinical studies state that wearable defibrillators had higher efficiency in terminating ventricular fibrillation (VF) and ventricular tachycardia (VT). Thus, the higher efficiency and accuracy of devices drive the expansion of the wearable defibrillator segment.

  • In April 2024, Stryker previewed a next-generation monitor/defibrillator, which got approved by the FDA. LifePak 35 has a touch screen, data manipulation, and connectivity with different devices. The software used in the defibrillator can aid in CPR administration, better battery life, and various communication features.

Application Insights

The home healthcare segment dominates the wearable cardiac devices market and is expected to grow at the fastest rate during the forecast period. The increasing preference for home healthcare in the population at the time of the outburst of the COVID-19 pandemic is contributing to the growth of the segment. Wearable devices allow monitoring and tracking of healthcare data and provide valuable insights to physicians from anywhere, resulting in a reduction in hospital visits. The rising awareness about wearable healthcare technology in people minimizes routine hospital visits and enhances the home healthcare segment.

  • In March 2024, a physician-owned healthcare company with a focus on heart health services was able to cut hospital cardiovascular readmission rates by 50%. These rates result from Cardiac Solutions' utilization of chronic care management and remote patient monitoring via an MD Revolution relationship. 26,689 individuals were assessed by Cardiac Solutions. Those who included remote care management in their therapy had a 30-day readmission rate of 7%, whereas those who did not had a rate of 15%.

Wearable Cardiac Devices Market Recent Developments

  • In May 2024, Samsung, a leading technology company, introduced its Galaxy Ring at the Mobile World Congress (MWC) early in the year. The organization confirmed the launch of its Galaxy Ring in the second half of 2024. The ring can be used to track health, with features for monitoring respiratory rate, heart rate, sleep movement, and onset time of sleep.
  • In May 2024, OMRON Healthcare India, an Indian subsidy of a Japanese medical equipment company, announced its partnership with AliveCor India, a leading company in personal electrocardiogram (ECG) technology, for the launch of the first home BPM+ECG Monitoring FDA-cleared device for the early management and detection of AliveCor’s FDA-cleared pocket-sized personal ECGs.
  • In May 2024, Vivalink, a leading player in digital healthcare solutions, introduced a technology solution designed for Holter monitoring and Mobile Cardiac Telemetry (MCT). The design includes advanced arrhythmia detection algorithms and remote patient monitoring (RPM) technologies to maintain deployment, increase patient care, and fulfill the demand for ambulatory ECG monitoring solutions.
  • In May 2024, Teltonika launched the multifunctional smart wristband system designed in association with Lithuanian industry and universities. The system has received the CE MDR (Class IIa) medical certification, which will open the door for the product to enter the medical device industry.

Wearable Cardiac Devices Market Companies

  • Heartbit Holdings Plc.
  • Qardio, Inc.
  • General Electric Company (GE Healthcare, Inc.)
  • iRhythm Technologies, Inc.
  • Boston Scientific (Preventice Solutions, Inc.)
  • ACS Diagnostics, Inc.
  • Hemodynamics Company LLC
  • Koninklijke Philips N.V. (BioTelemetry, Inc.)
  • Asahi Kasei Corporation (ZOLL Medical Corporation)
  • Vital Connect, Inc.
  • Baxter
  • Medtronic plc

Segments Covered in the Report

By Product

  • Defibrillator
  • Holter monitors
  • Patch
  • Others

By Application

  • Home Healthcare
  • Remote Patient Monitoring
  • Others

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global wearable cardiac devices market size is expected to increase USD 27.44 billion by 2033 from USD 3.01 billion in 2023.

The global wearable cardiac devices market will register growth rate of 24.73% between 2024 and 2033.

The major players operating in the wearable cardiac devices market are Heartbit Holdings Plc., Qardio, Inc., General Electric Company (GE Healthcare, Inc.), iRhythm Technologies, Inc., Boston Scientific (Preventice Solutions, Inc.), ACS Diagnostics, Inc., Hemodynamics Company LLC, Koninklijke Philips N.V. (BioTelemetry, Inc.), Asahi Kasei Corporation (ZOLL Medical Corporation), Vital Connect, Inc., Baxter, Medtronic plc, and Others.

The driving factors of the wearable cardiac devices market are the rising cases of cardiovascular diseases (CVD) and increase in the geriatric population.

North America region will lead the global wearable cardiac devices market during the forecast period 2024 to 2033.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Wearable Cardiac Devices Market 

5.1. COVID-19 Landscape: Wearable Cardiac Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Wearable Cardiac Devices Market, By Product

8.1. Wearable Cardiac Devices Market Revenue and Volume, By Product, 2024-2033

8.1.1 Defibrillator

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Holter monitors

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Patch

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Wearable Cardiac Devices Market, By Application

9.1. Wearable Cardiac Devices Market Revenue and Volume, By Application, 2024-2033

9.1.1. Home Healthcare

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Remote Patient Monitoring

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Wearable Cardiac Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.1.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.1.3.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.1.4.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.2.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.2.3.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.2.4.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.2.5.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.2.6.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.3.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.3.3.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.3.4.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.3.5.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.3.6.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.4.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.4.3.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.4.4.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.4.5.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.4.6.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.5.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.5.3.2. Market Revenue and Volume Forecast, By Application (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, By Product (2021-2033)

10.5.4.2. Market Revenue and Volume Forecast, By Application (2021-2033)

Chapter 11. Company Profiles

11.1. C&J Energy Services

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Calfrac Well Services

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. FTS International

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Keane Group

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Pro Petro Holding Corp.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. RPC Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Schlumberger

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Halliburton

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Baker Hughes

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Weatherford International

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client